AlloVir Inc
(NAS:ALVR)
$
0.7162
0.0161 (2.3%)
Market Cap: 82.37 Mil
Enterprise Value: -42.27 Mil
PE Ratio: 0
PB Ratio: 0.68
GF Score: 28/100 AlloVir Inc (ALVR) Transcripts
- Allovir Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Allovir Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Allovir Inc Discussion on the Potential Clinical Impact of Posoleucel for the Treatment of BK Viremia in Kidney Transplant Patients - Corporate Call TranscriptFeb 15, 2023
- Allovir Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Allovir Inc Multi-Virus Prevention Approach in the Management of Allo-HCT Patients - Corporate Call TranscriptDec 14, 2022
- Allovir Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Allovir Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Allovir Inc Virtual Investor Event Call TranscriptDec 13, 2021
- 1